1. Molecular Differences between Squamous Cell Carcinoma and Adenocarcinoma Cervical Cancer Subtypes: Potential Prognostic Biomarkers
   Alma D. Campos-Parra et al, 2022, Current Oncology CrossRef
2. Estrogen receptor 1 mutations in 260 cervical cancer samples from Chinese patients
   Xin‑Min Yang et al, 2019, Oncology Letters CrossRef
3. Integrated Transcriptome and Molecular Docking to Identify the Hub Superimposed Attenuation Targets of Curcumin in Breast Cancer Cells
   Rui Wang et al, 2023, International Journal of Molecular Sciences CrossRef
4. Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway
   Jiejun Hu et al, 2021, Frontiers in Oncology CrossRef
5. Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement
   Eugenia Girda et al, 2023, Gynecologic Oncology CrossRef
6. The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis
   Yang Zou et al, 2018, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis CrossRef
7. AKT and ERK dual inhibitors: The way forward?
   Zhe Cao et al, 2019, Cancer Letters CrossRef
8. RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocarcinoma tissues
   Guihua Jin et al, 2021, Aging CrossRef
9. Expression and clinical significance of CD90 and CD177 tumor stem cell markers in cervical cancer
   Qing Zhang et al, 2019, Oncology and Translational Medicine CrossRef